Claro Advisors LLC Edwards Lifesciences Corp Transaction History

Claro Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$81.41 - $94.33 $2,523 - $2,924	31 Added 0.57%	5,480 $516,000
Q1 2023 Apr 17, 2023	BUY	$74.26 - $84.51 $1,485 - $1,690	20 Added 0.37%	5,449 $450,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $69,051 - $88,401	-1,011 Reduced 15.7%	5,429 $405,000
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $557,060 - $826,058	6,440 New	6,440 $612,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $652,645 - $821,504	-6,401 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $926 - $1,104	9 Added 0.14%	6,401 $725,000
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $1,676 - $2,095	20 Added 0.31%	6,392 $662,000
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $5,192 - $5,984	66 Added 1.05%	6,372 $533,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $241,322 - $322,728	4,194 Added 198.58%	6,306 $436,000
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $786 - $1,215	15 Added 0.72%	2,112 $398,000
Q2 2019 Jul 24, 2019	SELL	$55.74 - $64.41 $836 - $966	-15 Reduced 0.71%	2,097 $387,000
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $814 - $1,088	17 Added 0.81%	2,112 $404,000
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $97,228 - $119,289	2,095 New	2,095 $365,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Claro Advisors LLC with notifications on news.